NCT04419298

Brief Summary

Previous report showed that 37% of patients with moderate to severe carbon monoxide (CO) poisoning experienced a myocardial injury, defined as elevated cardiac enzyme \[creatine kinase, CK-MB, and cardiac troponin I (TnI)\] or ischemic electrocardiogram (ECG) change. In other study, 24% of the patients with the myocardial injury after CO poisoning died during a median follow-up of 7.6 years. The myocardial injury was the major predictor of mortality. In addition, in the Taiwanese nationwide population-based cohort study, CO poisoning itself reported as a higher risk of a major adverse cardiovascular event. According to the previous study of investigators, among CO poisoned patients with myocardial injury, 74.4% of patients experienced CO-induced cardiomyopathy. All CO-induced cardiomyopathy recovered to normal status. In this situation, there is no definite approved reason why more cardiovascular events are occurred in CO poisoned patients with myocardial injury during long term follow-up period despite normalization of CO-induced elevated TnI and cardiac dysfunction. Two image cases related to cardiac magnetic resonance imaging (CMR) in acute CO poisoning previously reported. One image case reported that patient had mildly depressed left ventricular (LV) systolic function with hypokinesis of the anterior wall and regional akinesis of the inferior wall on the transthoracic echocardiography performed during hospitalization and late gadolinium-enhancement (LGE) images of CMR demonstrated multiple focal areas of high signal consistent with myocardial necrosis or fibrosis. Another image case reported an image case that in CMR, inferolateral mid-wall myocardial fibrosis, which was defined as LGE, was present despite the setting of a completely normal echocardiogram at 4-month follow-up in CO poisoned patients. Therefore, the investigators evaluate prevalence (frequency of LGE positive) and patterns (involved LV wall and range of LGE positive) of myocardial fibrosis (LGE positive) in acute CO-poisoned patients during acute (within seven days after CO exposure) and chronic phase (at 4-5 months after CO exposure) and whether LGE positive developed in acute phase have been changed through cardiac MRI performed at chronic phase. The investigators also evaluate LV ejection fraction and global longitudinal strain in transthoracic echocardiography performed at the ED (baseline) and within seven days (follow-up). The investigators also assessed the association between neurocognitive outcomes using the global deterioration scale (at 1, 6, and 12 months after CO exposure) and the presence of LGE positive.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 5, 2020

Completed
Last Updated

June 5, 2020

Status Verified

June 1, 2020

Enrollment Period

1.8 years

First QC Date

May 28, 2020

Last Update Submit

June 2, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Late gadolinium enhancement (LGE) in CMR

    Prevalence (percent) of presence of LGE in CMR

    Within 7 days after acute CO poisoning

  • LGE involved wall in CMR

    Injured left ventricular wall according to LGE in CMR

    Within 7 days after acute CO poisoning

Secondary Outcomes (9)

  • LGE size in CMR

    Within 7 days after acute CO poisoning

  • Change of LGE between first CMR and follow-up CMR

    Within 7 days after CO exposure and at 4-5 months after CO exposure

  • LV ejection fraction (EF) of TTE performed at the ED

    Within 3 hours at the ED

  • LV global longitudinal strain (GLS) of TTE performed at the ED

    Within 3 hours at the ED

  • LV EF of TTE performed during admission

    Within 7 days after CO exposure

  • +4 more secondary outcomes

Study Arms (1)

Acute CO poisoning with myocardial injury

A diagnosis of CO poisoning was made according to medical history and carboxyhaemoglobin \>5% (\>10% in smokers). Myocardial injury was defined as elevated high-sensitivity TnI level above the upper limit (\> 0.046 ng/mL) when measured in the emergency department (ED) or repeatedly within 24 hours after ED arrival.

Diagnostic Test: Cardiac MRI

Interventions

Cardiac MRIDIAGNOSTIC_TEST

1. Cardiac MRI be taken to acute CO poisoned patients with elevated TnI \[during acute (within 7 days after CO exposure) and chronic phase (at 4-5 months after CO exposure)\] 2. TTE be taken to acute CO poisoned patients with elevated TnI \[At the ED and during admission (within 7 days after CO exposure)\]

Also known as: Transthoracic echocardiography (TTE)
Acute CO poisoning with myocardial injury

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Acute CO poisoning with myocardial injury, which was defined as elevated TnI (reference range \< 0.045 ng/mL), within 24 hours after ED arrival.

You may qualify if:

  • Acute CO poisoning with myocardial injury, which was defined as elevated TnI (reference range \< 0.045 ng/mL), within 24 hours after ED arrival.

You may not qualify if:

  • Age \<19 years
  • No elevated TnI within 24 hours after ED arrival
  • Cardiac arrest upon ED arrival or before taking a CMR
  • Co-ingestion of cardiac toxic drugs
  • Transferred patients without admission
  • Declined to enrollment in the study
  • Impossible CMR due to artificial device
  • Calculated creatinine clearance (Ccr) \< 30 mL/min
  • Previous known history of hypersensitivity of gadolinium
  • History of acute coronary syndrome, heart failure, or cardiomyopathy
  • Patients who refuse CMR or fail to take a CMR although written informed consent was obtained
  • Impossible of interpretation of CMR although CMR was taken

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wonju Severance Christian Hospital

Wŏnju, Gangwon-do, 26426, South Korea

Location

Related Publications (1)

  • Cho DH, Ko SM, Son JW, Park EJ, Cha YS. Myocardial Injury and Fibrosis From Acute Carbon Monoxide Poisoning: A Prospective Observational Study. JACC Cardiovasc Imaging. 2021 Sep;14(9):1758-1770. doi: 10.1016/j.jcmg.2021.02.020. Epub 2021 Apr 14.

MeSH Terms

Conditions

Carbon Monoxide Poisoning

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Gas PoisoningPoisoningChemically-Induced Disorders

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 5, 2020

Study Start

August 1, 2017

Primary Completion

May 23, 2019

Study Completion

May 25, 2020

Last Updated

June 5, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations